Liu N - Search Results

1

Decoding frontotemporal and cell-type-specific vulnerabilities to neuropsychiatric disorders and psychoactive drugs.

Ji J, Chao H, Chen H, Liao J, Shi W, Ye Y, Wang T, You Y, Liu N, Ji J, Petretto E. Ji J, et al. Among authors: liu n. Open Biol. 2024 Jun;14(6):240063. doi: 10.1098/rsob.240063. Epub 2024 Jun 12. Open Biol. 2024. PMID: 38864245 Free PMC article.

2

Correction: O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.

Xu L, Ye Y, Tao Z, Wang T, Wei Y, Cai W, Wan X, Zhao P, Gu W, Gu B, Zhang L, Tian Y, Liu N, Tu Y, Ji J. Xu L, et al. Among authors: liu n. Oncogene. 2024 Jun;43(26):2051. doi: 10.1038/s41388-024-03045-w. Oncogene. 2024. PMID: 38773264 No abstract available.

3

The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study.

Xu Y, Luo X, Yuan B, Liang P, Liu N, Dong D, Ge W, Gu Q. Xu Y, et al. Among authors: liu n. J Antimicrob Chemother. 2024 Apr 2;79(4):820-825. doi: 10.1093/jac/dkae035. J Antimicrob Chemother. 2024. PMID: 38366379

4

A descriptive pharmacokinetic/pharmacodynamic analysis of ceftazidime-avibactam in a case series of critically ill patients with augmented renal clearance.

Xu Y, Tang J, Yuan B, Luo X, Liang P, Liu N, Dong D, Jin L, Ge W, Gu Q. Xu Y, et al. Among authors: liu n. Pharmacol Res Perspect. 2024 Feb;12(1):e01163. doi: 10.1002/prp2.1163. Pharmacol Res Perspect. 2024. PMID: 38149723 Free PMC article.

5

A Method for Evaluating the Green Economic Efficiency of Resource-Based Cities Based on Neural Network Improved DEA Model.

Shen Z, Liu N, Li X, Kang Z. Shen Z, et al. Among authors: liu n. Comput Intell Neurosci. 2022 Sep 8;2022:9521107. doi: 10.1155/2022/9521107. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 36120689 Free PMC article.

6

Indocyanine green clearance test as a predictor of linezolid overexposure in septic patients.

Xu Y, Qu C, Yan M, Gu Q, Liu N. Xu Y, et al. Among authors: liu n. Int J Antimicrob Agents. 2023 Dec;62(6):107006. doi: 10.1016/j.ijantimicag.2023.107006. Epub 2023 Oct 14. Int J Antimicrob Agents. 2023. PMID: 37839718 Free article. Clinical Trial.

7

The thermal instability of hydrogen-substituted graphdiyne and its role in lithium-sulfur batteries.

Eeso K, Wygant BR, Chen Z, Sarswat A, Lambert TN, Liu N. Eeso K, et al. Among authors: liu n. Chem Commun (Camb). 2024 Nov 13. doi: 10.1039/d4cc04459b. Online ahead of print. Chem Commun (Camb). 2024. PMID: 39535275

8

Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS.

Song Z, Wang Y, Zhang D, Wang T, Liu N, Gao L, Wang L, Yang J. Song Z, et al. Among authors: liu n. Int J Cancer. 2024 Nov 13. doi: 10.1002/ijc.35235. Online ahead of print. Int J Cancer. 2024. PMID: 39533880

9

Knowledge, attitude, and perception of exercises among post-hematopoietic stem cell transplant patients: A cross-sectional study.

Han N, Wu C, Liu N, Deng Y, Zhang L, Zhu Y. Han N, et al. Among authors: liu n. Medicine (Baltimore). 2024 Nov 8;103(45):e40036. doi: 10.1097/MD.0000000000040036. Medicine (Baltimore). 2024. PMID: 39533570

10

A novel multifunctional nanocomposite hydrogel orchestrates the macrophage reprogramming-osteogenesis crosstalk to boost bone defect repair.

Wang Y, Chen Y, Zhou T, Li J, Zhang N, Liu N, Zhou P, Mao Y. Wang Y, et al. Among authors: liu n. J Nanobiotechnology. 2024 Nov 13;22(1):702. doi: 10.1186/s12951-024-02996-2. J Nanobiotechnology. 2024. PMID: 39533396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,038 results

Search Page

Filters